<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_nreNWXa">Describing the initial results of a pragmatic, cluster randomized clinical trial to examine the impact of a multifaceted digital intervention for the prevention of type 2 diabetes mellitus in the primary care setting: intervention design, recruitment strategy and participants&apos; baseline characteristics of the PREDIABETEXT trial</title>
				<funder ref="#_JFvpQqm">
					<orgName type="full">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
				</funder>
				<funder ref="#_vEE7jZe">
					<orgName type="full">Health Research Institute of the Balearic Islands</orgName>
				</funder>
				<funder ref="#_bRcf7fu">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder ref="#_fy8Vbw2">
					<orgName type="full">Unio ́n Europea -NextGenerationEU</orgName>
				</funder>
				<funder ref="#_7DKGzhZ">
					<orgName type="full">Instituto de Salud Carlos III</orgName>
					<orgName type="abbreviated">ISCIII</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100004587</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2025 Mira-Martı ́nez, Zamanillo-Campos, Malih, Fiol-deRoque, Angullo-Martı ́nez, Jimenez, Serrano-Ripoll, Oña, Galmes-Panades, Go ḿez-Juanes, Konieczna, Miralles, Romaguera, Vidal-Thomasa, Llobera-Canaves, Garcı ́a-Toro, Gervilla-Garcı ́a, Vicens, Bulilete, Montaño, Gili, Roca, Colom and Ricci-Cabello. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. /fendo.2025.1524336 Frontiers in Endocrinology frontiersin.org</p>
				</availability>
				<date type="published" when="2025-03-31">31 March 2025</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sofı</forename><surname>´a Mira-Martı ´nez</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rocı</forename><surname>´o Zamanillo-Campos</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Narges</forename><surname>Malih</surname></persName>
							<email>narges.malih@ssib.es</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><forename type="middle">Antonia</forename><surname>Fiol-Deroque</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Research Network on Chronicity , Primary Care, and Health Promotion (RICAPPS) , Instituto de Salud Carlos III (ISCIII) , Madrid , Spain ,</note>
								<orgName type="department">Primary Care, and Health Promotion (RICAPPS)</orgName>
								<orgName type="laboratory">Research Network on Chronicity</orgName>
								<orgName type="institution">Instituto de Salud Carlos III (ISCIII)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Escarlata</forename><surname>Angullo-Martı ´nez</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rafael</forename><surname>Jimenez</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST) , Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST)</orgName>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>6</label> Department of Psychology , University of the Balearic Islands (UIB) , Palma , Spain ,</note>
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of the Balearic Islands (UIB)</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><surname>Jesu ´s Serrano-Ripoll</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Research Network on Chronicity , Primary Care, and Health Promotion (RICAPPS) , Instituto de Salud Carlos III (ISCIII) , Madrid , Spain ,</note>
								<orgName type="department">Primary Care, and Health Promotion (RICAPPS)</orgName>
								<orgName type="laboratory">Research Network on Chronicity</orgName>
								<orgName type="institution">Instituto de Salud Carlos III (ISCIII)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jose</forename><surname>´iva ´n Oña</surname></persName>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>7</label> Dra . Teresa Piqué Primary Health Care Center , Balearic Health Service , Palma , Spain ,</note>
								<orgName type="department">Dra</orgName>
								<orgName type="institution" key="instit1">Teresa Piqué Primary Health Care Center</orgName>
								<orgName type="institution" key="instit2">Balearic Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Aina</forename><forename type="middle">M</forename><surname>Galmes-Panades</surname></persName>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>8</label> Research Group on Nursing , Community &amp; Global Health , Health Research Institute of the Balearic Islands (IdISBa) , University Hospital Son Espases (HUSE) , Palma , Spain ,</note>
								<orgName type="department" key="dep1">Research Group on Nursing</orgName>
								<orgName type="department" key="dep2">Community &amp; Global Health</orgName>
								<orgName type="department" key="dep3">Islands (IdISBa)</orgName>
								<orgName type="institution" key="instit1">Health Research Institute of the Balearic</orgName>
								<orgName type="institution" key="instit2">University Hospital Son Espases (HUSE)</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<note type="raw_affiliation"><label>9</label> Physical Activity and Sport Sciences Research Group (GICAFE) , Institute for Educational Research and Innovation (IRIE) , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="department">Institute for Educational Research and Innovation (IRIE)</orgName>
								<orgName type="laboratory">Physical Activity and Sport Sciences Research Group (GICAFE)</orgName>
								<orgName type="institution">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<note type="raw_affiliation"><label>10</label> CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN) , Instituto de Salud Carlos III , Madrid , Spain ,</note>
								<orgName type="laboratory">CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN)</orgName>
								<orgName type="institution">Instituto de Salud Carlos III</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rocı</forename><surname>´o Go ´mez-Juanes</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Research Network on Chronicity , Primary Care, and Health Promotion (RICAPPS) , Instituto de Salud Carlos III (ISCIII) , Madrid , Spain ,</note>
								<orgName type="department">Primary Care, and Health Promotion (RICAPPS)</orgName>
								<orgName type="laboratory">Research Network on Chronicity</orgName>
								<orgName type="institution">Instituto de Salud Carlos III (ISCIII)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>11</label> University Institute of Health Science Research (IUNICS) , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="institution" key="instit1">University Institute of Health Science Research (IUNICS)</orgName>
								<orgName type="institution" key="instit2">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<note type="raw_affiliation"><label>12</label> Department of Medicine , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jadwiga</forename><surname>Konieczna</surname></persName>
							<affiliation key="aff9">
								<note type="raw_affiliation"><label>10</label> CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN) , Instituto de Salud Carlos III , Madrid , Spain ,</note>
								<orgName type="laboratory">CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN)</orgName>
								<orgName type="institution">Instituto de Salud Carlos III</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<note type="raw_affiliation"><label>13</label> Research Group on Nutritional Epidemiology &amp; Cardiovascular Physiopathology Frontiers in Endocrinology frontiersin.org Peking University People&apos;s Hospital , China</note>
								<orgName type="laboratory">Research Group on Nutritional Epidemiology &amp; Cardiovascular Physiopathology Frontiers in Endocrinology frontiersin.org</orgName>
								<orgName type="institution">Peking University People&apos;s Hospital</orgName>
								<address>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jero</forename><surname>´nima Miralles</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dora</forename><surname>Romaguera</surname></persName>
							<affiliation key="aff11">
								<note type="raw_affiliation"><label>12</label> Department of Medicine , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<note type="raw_affiliation"><label>13</label> Research Group on Nutritional Epidemiology &amp; Cardiovascular Physiopathology Frontiers in Endocrinology frontiersin.org Peking University People&apos;s Hospital , China</note>
								<orgName type="laboratory">Research Group on Nutritional Epidemiology &amp; Cardiovascular Physiopathology Frontiers in Endocrinology frontiersin.org</orgName>
								<orgName type="institution">Peking University People&apos;s Hospital</orgName>
								<address>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marı</forename><surname>´a</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Clara</forename><surname>Vidal-Thomasa</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joan</forename><surname>Llobera-Canaves</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Research Network on Chronicity , Primary Care, and Health Promotion (RICAPPS) , Instituto de Salud Carlos III (ISCIII) , Madrid , Spain ,</note>
								<orgName type="department">Primary Care, and Health Promotion (RICAPPS)</orgName>
								<orgName type="laboratory">Research Network on Chronicity</orgName>
								<orgName type="institution">Instituto de Salud Carlos III (ISCIII)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mauro</forename><surname>Garcı ´a-Toro</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Research Network on Chronicity , Primary Care, and Health Promotion (RICAPPS) , Instituto de Salud Carlos III (ISCIII) , Madrid , Spain ,</note>
								<orgName type="department">Primary Care, and Health Promotion (RICAPPS)</orgName>
								<orgName type="laboratory">Research Network on Chronicity</orgName>
								<orgName type="institution">Instituto de Salud Carlos III (ISCIII)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>11</label> University Institute of Health Science Research (IUNICS) , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="institution" key="instit1">University Institute of Health Science Research (IUNICS)</orgName>
								<orgName type="institution" key="instit2">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<note type="raw_affiliation"><label>12</label> Department of Medicine , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elena</forename><surname>Gervilla-Garcı</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST) , Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST)</orgName>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>7</label> Dra . Teresa Piqué Primary Health Care Center , Balearic Health Service , Palma , Spain ,</note>
								<orgName type="department">Dra</orgName>
								<orgName type="institution" key="instit1">Teresa Piqué Primary Health Care Center</orgName>
								<orgName type="institution" key="instit2">Balearic Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Catalina</forename><surname>Vicens</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<note type="raw_affiliation"><label>12</label> Department of Medicine , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<note type="raw_affiliation"><label>14</label> Health Research Institute of the Balearic Islands (IdISBa) , University Hospital Son Espases (HUSE) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Islands (IdISBa)</orgName>
								<orgName type="institution" key="instit1">Health Research Institute of the Balearic</orgName>
								<orgName type="institution" key="instit2">University Hospital Son Espases (HUSE)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Oana</forename><surname>Bulilete</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Research Network on Chronicity , Primary Care, and Health Promotion (RICAPPS) , Instituto de Salud Carlos III (ISCIII) , Madrid , Spain ,</note>
								<orgName type="department">Primary Care, and Health Promotion (RICAPPS)</orgName>
								<orgName type="laboratory">Research Network on Chronicity</orgName>
								<orgName type="institution">Instituto de Salud Carlos III (ISCIII)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Juan</forename><forename type="middle">Jose</forename><surname>´montaño</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST) , Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST)</orgName>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>6</label> Department of Psychology , University of the Balearic Islands (UIB) , Palma , Spain ,</note>
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of the Balearic Islands (UIB)</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Margalida</forename><surname>Gili</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Research Network on Chronicity , Primary Care, and Health Promotion (RICAPPS) , Instituto de Salud Carlos III (ISCIII) , Madrid , Spain ,</note>
								<orgName type="department">Primary Care, and Health Promotion (RICAPPS)</orgName>
								<orgName type="laboratory">Research Network on Chronicity</orgName>
								<orgName type="institution">Instituto de Salud Carlos III (ISCIII)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>11</label> University Institute of Health Science Research (IUNICS) , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="institution" key="instit1">University Institute of Health Science Research (IUNICS)</orgName>
								<orgName type="institution" key="instit2">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<note type="raw_affiliation"><label>12</label> Department of Medicine , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Miquel</forename><surname>Roca</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>11</label> University Institute of Health Science Research (IUNICS) , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="institution" key="instit1">University Institute of Health Science Research (IUNICS)</orgName>
								<orgName type="institution" key="instit2">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<note type="raw_affiliation"><label>12</label> Department of Medicine , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Antoni</forename><surname>Colom</surname></persName>
							<affiliation key="aff12">
								<note type="raw_affiliation"><label>13</label> Research Group on Nutritional Epidemiology &amp; Cardiovascular Physiopathology Frontiers in Endocrinology frontiersin.org Peking University People&apos;s Hospital , China</note>
								<orgName type="laboratory">Research Group on Nutritional Epidemiology &amp; Cardiovascular Physiopathology Frontiers in Endocrinology frontiersin.org</orgName>
								<orgName type="institution">Peking University People&apos;s Hospital</orgName>
								<address>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<note type="raw_affiliation"><label>15</label> Son Serra-La Vileta Primary Health Care Center , Balearic Health Service , Palma , Spain , Department of Geography ,</note>
								<orgName type="department">Department of Geography</orgName>
								<orgName type="institution" key="instit1">Son Serra-La Vileta Primary Health Care Center</orgName>
								<orgName type="institution" key="instit2">Balearic Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ignacio</forename><surname>Ricci-Cabello</surname></persName>
							<email>ignacio.ricci@idisba.es</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Health Research Institute of the Balearic Islands (IdISBa) , Palma de Mallorca , Spain ,</note>
								<orgName type="institution">Health Research Institute of the Balearic Islands (IdISBa)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB) , Palma de Mallorca , Spain ,</note>
								<orgName type="department">Research Group in Primary Care and Promotion-Balearic Islands Community (GRAPP-caIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Primary Care Research Unit of Mallorca , Balearic Islands Health Service , Palma , Spain ,</note>
								<orgName type="department">Primary Care Research Unit of Mallorca</orgName>
								<orgName type="institution">Balearic Islands Health Service</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<note type="raw_affiliation"><label>12</label> Department of Medicine , University of the Balearic Islands , Palma , Spain ,</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of the Balearic Islands</orgName>
								<address>
									<settlement>Palma</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xiantong</forename><surname>Zou</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jiaman</forename><surname>Xu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jiawei</forename><surname>Meng</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mira</forename><surname>-Martínez</surname></persName>
						</author>
						<author>
							<affiliation key="aff13">
								<note type="raw_affiliation">Boston University , United States Jiahe Li ,</note>
								<orgName type="department">Jiahe Li</orgName>
								<orgName type="institution">Boston University</orgName>
								<address>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<note type="raw_affiliation">University of Pittsburgh , United States</note>
								<orgName type="institution">University of Pittsburgh</orgName>
								<address>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<note type="raw_affiliation">Trine University , United States Xinhang Wang ,</note>
								<orgName type="department">Xinhang Wang</orgName>
								<orgName type="institution">Trine University</orgName>
								<address>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<note type="raw_affiliation">Stanford University , United States (NUTRECOR) ,</note>
								<orgName type="laboratory">NUTRECOR</orgName>
								<orgName type="institution">Stanford University</orgName>
								<address>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<note type="raw_affiliation">University of the Balearic Islands (UIB) , Palma de Mallorca , Spain</note>
								<orgName type="institution">University of the Balearic Islands (UIB)</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_e6WXvgU">Describing the initial results of a pragmatic, cluster randomized clinical trial to examine the impact of a multifaceted digital intervention for the prevention of type 2 diabetes mellitus in the primary care setting: intervention design, recruitment strategy and participants&apos; baseline characteristics of the PREDIABETEXT trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2025-03-31">31 March 2025</date>
						</imprint>
					</monogr>
					<idno type="MD5">6232D75439F8BF5341559EFE7E98C079</idno>
					<idno type="DOI">10.3389/fendo.2025.1524336</idno>
					<note type="submission">RECEIVED 07 November 2024 ACCEPTED 16 January 2025</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T14:09+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_DajbDV8">prediabetic state</term>
					<term xml:id="_V2JQzNa">preventive health services</term>
					<term xml:id="_8PRXW8C">clinical trial</term>
					<term xml:id="_x9KxvjG">primary health care</term>
					<term xml:id="_buV4Zzd">patient recruitment</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_k2AH4PZ"><p xml:id="_3YbzkQZ"><s xml:id="_hRAzhB3">Introduction: i) to describe PREDIABETEXT, a novel digital intervention for the prevention of type 2 diabetes; ii) to examine the performance of a strategy for virtual recruitment of participants in a trial to assess its impact, and; iii) to determine the baseline characteristics of the enrolled participants.</s></p><p xml:id="_FbZz2qF"><s xml:id="_ZncV3gu">Methods: We developed PREDIABETEXT in a multistage process involving systematic literature reviews and qualitative research with end users (primary care patients and professionals).</s><s xml:id="_JeMknGP">We combined multiple virtual strategies (SMS, phone calls, promotional videos) to recruit healthcare professionals and their patients.</s><s xml:id="_pMde3Gs">We collected baseline data from patients (sociodemographic, behavioral and clinical) and healthcare professionals (sociodemographic and professional experience).</s></p><p xml:id="_9JQ5Zqj"><s xml:id="_AsPxuWz">Results: The intervention consisted in delivering personalized short text messages supporting lifestyle behavior changes to people at risk of type 2 diabetes; and online training to their primary healthcare professionals.</s><s xml:id="_zpGtVgk">We recruited 58/133 (43.6%) professionals (30 doctors; 28 nurses) from 16 centers.</s><s xml:id="_TTfCk3q">Most professionals (83%) were women [mean (SD) age 49.69 (10.15)].</s><s xml:id="_5wwkhpr">We recruited 365/976 (37.4%) patients (54.5% women, 59.82 (9.77) years old.</s><s xml:id="_cwtNKR8">Around half (55.3%) presented obesity (BMI ≥25), 65% hypertension, 43.3% hypercholesterolemia, and 14.8% hypertriglyceridemia.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kgr5gJJ">Conclusions:</head><p xml:id="_xRDsvuW"><s xml:id="_2ukTMSN">The PREDIABETEX trial successfully recruited a representative sample of patients at risk of type 2 diabetes and their healthcare providers.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.389" lry="841.663"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7KWbtaT">Introduction</head><p xml:id="_WYWTvDE"><s xml:id="_qNcc4Hg">Prediabetes is an intermediate state of hyperglycemia with glycemic parameters above normal but below the diabetes threshold.</s><s xml:id="_SPT2agp">The World Health Organization (WHO) defines prediabetes based on impaired fasting glucose (IFG -fasting plasma glucose 6.1-6.9 mmol/L), impaired glucose tolerance (IGT -2 h plasma glucose of 7.8-11.0</s><s xml:id="_vsnKTuu">mmol/L after ingestion of 75 g of oral glucose load), or a combination of the two based on a 2 h oral glucose tolerance test <ref type="bibr" target="#b0">(1)</ref>.</s></p><p xml:id="_79PZMcn"><s xml:id="_U6UJjsQ">The global prevalence of IGT in 2021 was 9.1% (464 million) and is projected to increase to 10.0% (638 million) in 2045.</s><s xml:id="_u4SEUfE">The global prevalence of IFG in 2021 was 5.8% (298 million) and is projected to increase to 6.5% (414 million) in 2045 <ref type="bibr" target="#b1">(2)</ref>.</s><s xml:id="_KhbadeS">About 25% of adults with prediabetes will progress into T2DM within 3-5 years (3) and on a lifetime scale, 70% of individuals with prediabetes will develop overt diabetes <ref type="bibr" target="#b3">(4)</ref>.</s><s xml:id="_nMbYvyU">In addition to being more likely to develop diabetes, individuals with prediabetes are generally more prone to develop pathologies such as diabetic retinopathy, neuropathy, nephropathy, and macrovascular complications <ref type="bibr" target="#b4">(5)</ref>.</s><s xml:id="_bmbEmQz">Further, long-term consequences of diabetes lead to a lower quality of life, a significant increase in healthcare costs, and death <ref type="bibr" target="#b5">(6)</ref>.</s></p><p xml:id="_4u8fXsY"><s xml:id="_aJGGR5w">Lifestyle interventions can effectively prevent progression to diabetes <ref type="bibr" target="#b6">(7)</ref><ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref>.</s><s xml:id="_qcQ7arF">Effective treatments include the yearlong behavioral lifestyle change program based on the Diabetes Prevention Program (DPP), which decreased type 2 diabetes incidence by 58% over 3 years in the landmark DPP RCT <ref type="bibr" target="#b9">(10)</ref>.</s><s xml:id="_cYYyuDT">Unfortunately, few people participate in high intensity diabetes prevention programs.</s><s xml:id="_nUHaVZD">Taking the DPP as an example, only a third patients referred to a DPP initiate the program, and among those who initiate, only 32% remain in the program until completion <ref type="bibr" target="#b10">(11)</ref> Barriers to participation and retention in this high intensity, face-to-face program include lack of time and inability or unwillingness of participants to commit to a long-term program <ref type="bibr" target="#b11">(12)</ref>.</s></p><p xml:id="_RNzb2zY"><s xml:id="_FY8ZwE6">Digitally delivered, lower-intensity interventions may contribute to address these barriers.</s><s xml:id="_YQtPhVd">They have the potential to be a low-cost, massively available, and sustainable strategy for health systems to improve population health.</s><s xml:id="_VwNG3Qj">Recent systematic reviews examining the use of mobile health interventions among people with prediabetes observed a lack of significant effect on the incidence of T2DM, and inconsistent results in weight loss, body mass index, and waist circumference changes <ref type="bibr" target="#b12">(13,</ref><ref type="bibr" target="#b13">14)</ref>.</s><s xml:id="_2RYDVt5">However, this area of research is still in its infancy, and the available evidence of this type of intervention is limited by the small number and methodologic weaknesses of previous trials <ref type="bibr" target="#b14">(15)</ref>.</s></p><p xml:id="_GkYKEnR"><s xml:id="_zVK2FEx">To contribute to address this gap, we developed PREDIABETEXT, a new theory-based, multifaceted, digital intervention; and set up a cluster randomized clinical trial to evaluate its impact on diabetes prevention and cardiovascular risk factors.</s></p><p xml:id="_tQzcq8k"><s xml:id="_U9KQFnJ">The aims of this paper are to: i) describe the design, components and structure of the PREDIABETEXT intervention; ii) describe de design and performance a novel virtual participant recruitment strategy, and; iii) report the baseline sociodemographic and clinical characteristics of the recruited participants.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Afm7a6t">Material and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sjjeKJP">Intervention design and development</head><p xml:id="_AKBnT7M"><s xml:id="_mwZXw4n">The process for the development of the PREDIABETEXT intervention was based on the MRC Guidance for the Development of Complex Interventions <ref type="bibr" target="#b15">(16)</ref>.</s><s xml:id="_8CHsw2Q">This study has five phases.</s><s xml:id="_fSqqmDA">Each phase had a variety of tasks separated into sub-stages.</s><s xml:id="_fjPPhPY">The first four phases entailed designing, pilot testing, and modification of the treatments, while phase 5 included a phase II clinical trial with embedded qualitative research to evaluate the interventions and trial processes.</s><s xml:id="_RMx4HY8">The intervention design was informed by formative qualitative research with end-users.</s><s xml:id="_zqrsGFK">More specifically, we conducted 15 in depth semi-structured interviews with people at risk of type 2 diabetes to explore their views (acceptability and perceived utility) about the potential role of mHealth interventions for diabetes prevention, understand how a mHealth intervention may address the unmet needs of people with prediabetes for healthy lifestyle behavior, and to identify patientelicited recommendations about how to optimize its impact.</s><s xml:id="_Kbg4HsR">In addition, we conducted 15 in depth semi-structured interviews with primary care doctors and nurses to explore the acceptability, perceived usefulness, and suggestions regarding an educational co-intervention targeting healthcare professionals.</s><s xml:id="_Eywuhx4">All the interviews were audio-recorded, transcribed and analyzed using thematic analysis <ref type="bibr" target="#b16">(17)</ref>.</s></p><p xml:id="_YEfSy2Y"><s xml:id="_uP3HP6Y">The PREDIABETEXT co-intervention targeted to people at risk of type 2 diabetes was then developed thought a number of iterative workshops with a multidisciplinary team of primary care doctors and nurses, endocrinologists, nutritionists, sports scientists, psychologists, and pharmacists.</s><s xml:id="_czQ8kPU">Three patients were actively involved to ensure the content was appropriate and understandable.</s><s xml:id="_edrCDcs">Two diabetes experts reviewed the pre-final draft of the intervention to ensure its comprehensiveness and alignment with current guidelines.</s><s xml:id="_TDzWfDQ">The intervention content was framed in short text messages that could be delivered to patients mobile phones through the Balearic Islands Health Service messaging platform.</s><s xml:id="_q5VBHKJ">Once the intervention was developed, we piloted it during one month with 21 people with prediabetes to examine its acceptability, relevance, and perceived impact.</s><s xml:id="_GnSMfAJ">Following the pilot study, we conducted individual semistructured interviews with 12 patients diverse in terms of socioeconomic level to explore their experience of using the system.</s><s xml:id="_6QFc3W9">The results were used to fine-tunning the intervention.</s></p><p xml:id="_448xNjw"><s xml:id="_GHvf7av">The PREDIABETEXT co-intervention targeted to primary healthcare professionals consisted in an educational intervention to raise awareness about the importance of T2DM prevention, increase knowledge about effective strategies for diabetes prevention, improve knowledge about brief counseling techniques, and enhance communication skills.</s><s xml:id="_vQhfYCS">The intervention was developed by members of the research team (endocrinologists, nutritionists, GPs, nurses, and the managers for the continuous education to primary care professionals in the Balearic Islands).</s><s xml:id="_q9pTwnU">The contents were made available through an online platform from the Mallorca Primary Healthcare Teaching Unit.</s><s xml:id="_XvBNhsU">We piloted this educational intervention with ten primary care and nurses, who received the intervention contents and completed an ad-hoc questionnaire about its usefulness and suggestions for improvement.</s><s xml:id="_qPHWump">The intervention was then refined based on their feedback.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sZhYRKC">BOX 1 Selection criteria in the PREDIABETEXT trial</head><p xml:id="_X9UdeKt"><s xml:id="_6zswE2f">Primary health care professionals -We included general practitioners (GPs) and nurses from primary care centers located in Mallorca (Balearic Islands, Spain).</s></p><p xml:id="_RbqRe4z"><s xml:id="_wBPhGCE">-We excluded those planning to relocate to a different center during the study period and those who declined to participate.</s><s xml:id="_2KrwVnR">Patients -We included adult population between the ages of 18 and 75 years registered in the patient list of one of the primary healthcare professionals recruited in the PREDIABETEX trial.</s></p><p xml:id="_mWnrghd"><s xml:id="_Z73KUjB">-We included patients with HbA1c 6% to 6.4% registered in the last three months; or with two consecutive values of fasting plasma glucose between 110-125 mg/dL, or both.</s></p><p xml:id="_G8jt8QX"><s xml:id="_v4rK5we">-We excluded patients with a registered diagnosis of type 2 diabetes; with a prescription of any type of antidiabetic medication; with a history of pregnancy during the previous 12 months; with no access to a mobile device to capable of receiving SMS, not able to read Spanish, or with a severe mental condition.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_BhR6d5D">Study design</head><p xml:id="_BTxsH3X"><s xml:id="_uPZHqPJ">To assess the impact of PREDIABETEXT, we designed a sixmonth, three-arm, cluster randomized, clinical trial (NCT05110625).</s><s xml:id="_pudemba">A detailed description of the trial protocol is available elsewhere.</s><s xml:id="_MPehJj9">Briefly, participating primary healthcare professionals (physicians and nurse) were randomized by computer-generated random numbers to intervention A group (patient text messaging intervention), intervention B group (patient text messaging intervention + providers online education intervention), or control group (usual care).</s><s xml:id="_z6Ax8gw">Selection criteria for both primary care patients and professionals is described in Box 1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_p92GeTM">Outcomes</head><p xml:id="_7gVdq7S"><s xml:id="_hDPSsT3">The primary outcome of the study was HbA1c at 6 months follow-up.</s><s xml:id="_QzqeGPN">Secondary outcomes included various clinical, physiological, motivational, and behavioral measures.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ccKtCXa">Recruitment strategy</head><p xml:id="_JcYgyzS"><s xml:id="_77yrTVH">To maximize an efficient use of constrained resources, we designed a novel, fully virtual strategy to recruit participants into the trial.</s><s xml:id="_G6tXtP5">This strategy involved two stages: 1) recruitment of healthcare professionals, and 2) recruitment of patients from the already recruited professionals.</s></p><p xml:id="_MbyS5W2"><s xml:id="_7XrBWBq">In the first stage, eligible healthcare professionals received an email invitation to participate in the study, with an enclosed participant information sheet.</s><s xml:id="_uGNGKRA">Subsequently, we phoned them to offer additional information about the study (if needed), and to seek informed consent.</s><s xml:id="_heUkNJa">All the informed consents were obtained telephonically, audio-recorded, and stored in a secure server.</s><s xml:id="_F8FaEy6">In the second stage, with support from the Information Service platform (see acknowledgments), we obtained a list of eligible patients from data extracted from the Balearic Islands primary care database.</s><s xml:id="_SACv3tV">Computer-generated random numbers were used to assign recruited family physicians and nurses to one of three research arms.</s><s xml:id="_ZrYN4ry">Their patients received invitations to participate in the trial and offered the intervention based on the healthcare professional arm allocation.</s><s xml:id="_mGqgf7H">concealment of allocations was carried out at the healthcare professional level (clusters).</s><s xml:id="_6c7hgxd">Through the text messaging platform owned by the Balearic Islands Health Service, we sent potential participants an SMS invitation to take part in the study to patients from healthcare professionals who had already consented to participate in our trial.</s><s xml:id="_qMfWJZ4">Along a brief invitation, the SMS included a link to a webpage containing: detailed information about the study, the Patient Information Sheet, and a video in which representatives of healthcare professionals and patients who had participated in the development and initial evaluation stages of the intervention explained the study (see online Appendix A).</s><s xml:id="_JuA9nGc">After 48 hours, a research assistant contacted the individuals by phone to extend a formal invitation to participate in the study, provide any additional information, and record their informed consent (also audio-recorded over the phone).</s><s xml:id="_CT3NpdV">Potential participants could opt out to be reached by phone in case they requested it through a form in the study website.</s><s xml:id="_F27Cjdk">New blood tests were ordered to confirm the eligibility of individuals with a blood test result registered more than three months before consenting to participate.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mm8ZWrk">Data collection</head><p xml:id="_hy8KPZa"><s xml:id="_F3rafg6">Immediately after recruitment baseline data of the participants lifestyle behavior was collected via a phone semi-structured interview using validated instruments:</s></p><p xml:id="_JGH5tRz"><s xml:id="_8fRGdgG">-Adherence to the Mediterranean diet (MEDAS questionnaire).</s><s xml:id="_AjPsbwJ">A score &lt;9 was categorized as low adherence, ≥9 good adherence <ref type="bibr" target="#b17">(18)</ref>.</s></p><p xml:id="_D4UPgdV"><s xml:id="_U9hXgrv">-Physical activity levels (REGICOR Short form Physical Activity Questionnaire) <ref type="bibr" target="#b18">(19)</ref>.</s><s xml:id="_tCcKrbk">Participants were classified as not very active (&lt;300 METs min/weak), active (600-1200 METs min/weak), and very active (&gt;1200 METs min/weak).</s></p><p xml:id="_bn24U3j"><s xml:id="_xRx4KdS">-Sedentary behavior (physical activity questionnaire utilized for the Nurses' Health Study) <ref type="bibr" target="#b19">(20)</ref>.</s></p><p xml:id="_w9sMXpq"><s xml:id="_gt8A8Vj">-Smoking behavior (adapted version of the Global Adult Tobacco Survey (GATS) questionnaire).</s><s xml:id="_YgFVFhC">Participants categorized as past smokers, never smokers, or current smokers <ref type="bibr" target="#b20">(21)</ref>.</s></p><p xml:id="_VTfrqqw"><s xml:id="_6rXUe3b">-Alcohol consumption, quantified in grams based on a validated calculator <ref type="bibr" target="#b21">(22)</ref>.</s></p><p xml:id="_48RQuHq"><s xml:id="_JcaE5Dt">Subsequently, patients were invited to visit with the research nurse, who conducted anthropometric measurements and collected blood samples.</s><s xml:id="_mdQbFCu">Patients could choose to have the visit in their primary care center or in the reference hospital.</s></p><p xml:id="_EppqF62"><s xml:id="_t4KD6xb">-Blood pressure (BP): normal BP (Systolic BP &lt;130 and/or Diastolic BP &lt;85 mmHg), Prehypertension (Systolic BP 130 to 139 and/or Diastolic BP 85 to 89 mmHg), and Hypertension (Systolic BP ≥140 and/or Diastolic BP ≥90 mmHg) <ref type="bibr" target="#b22">(23)</ref>.</s></p><p xml:id="_wfMWSPT"><s xml:id="_TEtbQZA">-Cardiovascular disease (CVD) was assessed using the REGICOR-Framingham risk equation, validated for the Spanish adult population aged 35-74 years <ref type="bibr" target="#b23">(24)</ref>.</s><s xml:id="_gTtTWPw">Participants were categorized as low risk (&lt;5%) and moderate or high risk ≥5%.</s></p><p xml:id="_a9wcJct"><s xml:id="_gWayN4r">-Insulin resistance was calculated using the Homeostasis model assessment (HOMA) <ref type="bibr" target="#b24">(25)</ref>.</s></p><p xml:id="_K6KgN4s"><s xml:id="_zba4jnW">-Abdominal obesity (AO) was determined as Waist Circumference (WC) &gt;102 cm for men and &gt;88 cm for women, according to WHO criteria.</s><s xml:id="_CTbzAHz">AO was defined by the Waist to Hip Ratio (WHR) as values &gt; 0.90 for men and &gt; 0.85 for women <ref type="bibr" target="#b25">(26)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_rdnZ8Jx">Sample size estimation</head><p xml:id="_7ZjCRwp"><s xml:id="_j5rbSfp">The sample size calculation was designed to detect clinically relevant differences in HbA1c outcomes between intervention and control groups, not to identify subgroup differences at baseline.</s><s xml:id="_KXkpyyE">A total of 420 patients (140 per group) and 42 primary healthcare providers (10 patients per provider) were planned.</s><s xml:id="_4nJyeBZ">This calculation assumed 80% power, an intraclass correlation coefficient of 0.04, a design effect of 1.36, and a 10% dropout rate.</s><s xml:id="_tPxHkW7">Detecting a difference of at least 0.3% in HbA1c (SD = 0.8%) was considered sufficient, based on previous research, to demonstrate statistically significant differences in diabetes incidence in a future phase III trial with extended follow-up.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5bYCTrv">Statistical methods</head><p xml:id="_TA43BDR"><s xml:id="_8qUZR2q">We used descriptive statistics for reporting the number (percentage) for categorical variables, and mean (SD) for continuous variables.</s><s xml:id="_wKDxQQF">Chi-square test, independent t-test and ANOVA were used for between-group comparisons as needed, including post-hoc test (Bonferroni correction) for significant pvalues.</s><s xml:id="_aj7vg9n">Nonparametric tests were used in non-normal variables (Kruskal-Wallis or Mann-Whitney U tests).</s><s xml:id="_V2T23NQ">All the statistical analysis was conducted using IBM SPSS Statistics for Windows, Version 25.0 (IBM Corp., Armonk, NY).</s><s xml:id="_5rtVxaA">P value of &lt;0.05 was considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bxSr3hc">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PGgv4B6">Description of the interventions</head><p xml:id="_R4WcHZP"><s xml:id="_p4SYBDt">The co-intervention targeted to patients at risk of T2DM consisted in sending three weekly SMS short text messages supporting lifestyle change behavior (motivation, type of food, portions, physical activity, sedentary lifestyle, etc.).</s><s xml:id="_gbdcxmz">This intervention is based on the Behaviour Change Wheel, a framework for describing, designing and evaluating behavior change strategies <ref type="bibr" target="#b26">(27)</ref>.</s><s xml:id="_jhYnpgv">The messages are based on a total of 22 different well-established behavior change techniques, the most frequents ones being "Instruction on how to perform a behavior", and "Health consequences" <ref type="bibr" target="#b27">(28)</ref>.</s><s xml:id="_jEbPUpQ">Messages are personalized based on participants characteristics (BMI, alcohol drinking and smoking behavior, gender, and having or not internet access through their phones).</s><s xml:id="_EN7Y25B">Of the 71 messages delivered over the six months intervention period around 40% focused on healthy diet, 32% on physical activity, 12% on information about diabetes and diabetes prevention, and 10% on motivational strategies.</s></p><p xml:id="_hjbfCyC"><s xml:id="_8rehFfP">The intervention targeted to healthcare professionals consisted in a one-month online course about the management of patients with prediabetes at the primary healthcare level.</s><s xml:id="_wmenjBw">Main topics addressed were: epidemiology, diagnostic criteria, motivational interviewing, treatment, and monitoring and follow up.</s><s xml:id="_nAAqnu6">This online educational intervention offered support of different activities-including solving clinical cases and watching clinical practice simulation videos.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_TPyYNSh">Recruitment and characteristics of the healthcare professionals</head><p xml:id="_DAKtGER"><s xml:id="_dnd5cKa">Of 172 healthcare professionals who received an initial invitation by email, 133 confirmed meeting the eligibility criteria during phone interviews.</s><s xml:id="_mAbJzkU">Among them, 58 professionals (30 doctors; 28 nurses) from 16 centers were enrolled and completed the baseline telephone interview (recruitment rate: 58/133 = 43.6%).</s><s xml:id="_yxguKSb">Most professionals (83%) were women [mean (SD) age 49.69 <ref type="bibr">(10.15)</ref>].</s><s xml:id="_2DARHBy">20 professionals were allocated to the control group, 18 to intervention group A, and 20 to intervention group B (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_vxhKf4c">Total mean (SD) number of patients assigned per healthcare professional was 1924.12 (387.31).</s><s xml:id="_EprsSAj">No relevant differences were observed between the three groups (Table <ref type="table" target="#tab_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DDu7JWx">Recruitment and characteristics of participating patients</head><p xml:id="_wdawEAG"><s xml:id="_ZUwcstx">Patient recruitment is shown in Figure <ref type="figure" target="#fig_0">1</ref>.</s><s xml:id="_DQQK745">From data extracted from electronic health records, we identified an overall population of 7,116 patients potentially meeting the eligibility criteria described in Box 1. Their sociodemographic and clinical characteristics of the overall are available in Online Appendix B. We sent SMS recruitment invitations to a sample of 1,233 patients.</s><s xml:id="_qCg8NSM">Our recruitment team successfully phoned 1,056 patients, of which 975 confirmed meeting the eligibility criteria.</s><s xml:id="_cHHWhjb">A total of 534/975 (54.78%) accepted to participate in the trial, and provided informed consent.</s><s xml:id="_KP4BeCf">However, 67 were excluded because failed to attend their appointment with the research nurse; and 102 were excluded due to no longer meeting the eligibility criteria for prediabetes according to the baseline blood test results.</s><s xml:id="_rCD6gyk">Therefore, we successfully enrolled and collected full baseline data from 365/1056 invited over the phone, yielding a recruitment rate of 34.5%.</s><s xml:id="_XS2Y4KQ">Recruitment and baseline data collection lasted 27 weeks (from 18 November 2021 to 31 May 2022).</s><s xml:id="_X7PWFCb">Recruitment and baseline interviews cost 14,230€ (39€ per enrolled participant); and anthropometric and blood sample extraction and analysis 6,013€ (16.5€ per enrolled participant).</s></p><p xml:id="_4weRYqn"><s xml:id="_RvU9C5w">The characteristics of the enrolled participants are described in Table <ref type="table" target="#tab_1">2</ref>. Patients were allocated to intervention group A (n=106), intervention group B (n=140), and control group (n=119).</s><s xml:id="_aFRrcyF">The three groups were balanced for all sociodemographic and clinical characteristics, with the exception of DBP, which was substantially higher in the intervention A than in the control group (78.75 and 74.60, respectively).</s></p><p xml:id="_npGWDZS"><s xml:id="_FbT4NwS">The 365 recruited participants were representative of the overall sample of 7,116 potential participants in terms of gender (53.6% women in the overall sample vs 54.5% in the recruited sample), mean age (60.9 vs 59.8), total cholesterol (198.3 vs 194.7),</s><s xml:id="_9JvRAPb">HDL cholesterol (49.1 vs 49.7 mg/dl), LDL cholesterol (120.97 vs 117.7 mg/dl), triglycerides (147.4 vs 141.1 mg/dl), HbA1c (6.11% vs 6.13%) and blood glucose (104.5 vs 104.3 mg/dl).</s><s xml:id="_gPv6xej">Appendix C shows the total Baseline sociodemographic and clinical characteristics of the patients enrolled in the PREDIABETEXT trial, by gender.</s></p><p xml:id="_XfAhJ82"><s xml:id="_TnBmjzC">The lifestyle characteristics of the study participants are shown in Table <ref type="table" target="#tab_1">2</ref>. Notably, only 32.6% of individuals showed good adherence to the Mediterranean diet.</s><s xml:id="_PRGWkkX">Additionally, it was observed that only 47.6% of the study participants were physically active.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uregkVG">Discussion</head><p xml:id="_49beWfZ"><s xml:id="_6hq4mW8">PREDIABETEXT, a novel, evidence-based, multifaceted, digital intervention to prevent type 2 diabetes, has been successfully designed following state-of-the-art methods with heavy involvement from end users through formative qualitative research.</s><s xml:id="_KCZNVPE">Baseline results from a pragmatic cluster randomized controlled trial to evaluate the efficacy of the PREDIABETEXT</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CkpTeDF">Trial recruitment</head><p xml:id="_56CMhjt"><s xml:id="_ryHmJyE">Effective recruitment of research participants is essential for successful randomized controlled trials and remains one of the most challenging and labor-intensive aspects of conducting research.</s><s xml:id="_hZqPaFR">The success of the recruitment strategy in this trial not only ensured sufficient sample size but also balanced distribution across intervention arms, reducing bias and facilitating the robust evaluation of covariates' effects on outcomes.</s><s xml:id="_EK6BpAy">This achievement underscores the trial's capacity to meet its scientific and translational goals.</s><s xml:id="_TD8yab7">It causes missed clinical trial deadlines, leads to increased costs, and consumes more time than any other aspect of clinical trials <ref type="bibr" target="#b28">(29)</ref>.</s><s xml:id="_Q8zk66D">To make a more efficient use of limited resources, in this trial we followed a fully virtual recruitment strategy.</s><s xml:id="_dAfZTdB">By the time we started inviting healthcare professionals to participate, the coronavirus crisis was still not over.</s><s xml:id="_ShphDMN">Despite initial concerns about potential reluctance, the recruitment rates (43.6% and 32.1% for healthcare professionals and patients, respectively) were acceptablesuccessfully meeting the recruitment targets within our 6 months' timeline.</s><s xml:id="_rPQGtEX">In comparison to similar studies, the recruitment rate for surgeons in a study involving patients with prediabetes was 14.8% and 3.9% for the patients <ref type="bibr" target="#b29">(30)</ref>.</s><s xml:id="_9UgTgSC">Another clinical trial study among</s></p><p xml:id="_ubCZNUS"><s xml:id="_kbgFBrk">TABLE 2 Continued total (n=365) Control (n=119) Intervention A (SMS) (n=106) Intervention B (SMS + training) (n=140) P value $ Physical activity level Not very active, n (%) 191 (52.4%) 69 (58.0%) 55 (51.9%) 67 (47.9%) 0.456* Active, n (%) 83 (22.7%) 22 (18.5%)</s><s xml:id="_HUvdVXC">23 (21.7%) 38 (27.1%)</s><s xml:id="_KSc2vqh">Very active, n (%) 91 (24.9%) 28 (23.5%)</s><s xml:id="_hSx8DJA">28 (26.4%)</s><s xml:id="_rFkSQND">35 (25.0%)</s><s xml:id="_TE2NZuD">Total energy expenditure in physical activity (METs minutes/week), mean (SD) 1983.78</s><s xml:id="_CcBzGXP">(2365.91)</s><s xml:id="_n6mdbqT">1987.94</s><s xml:id="_hRaSEjX">(2413.43)</s><s xml:id="_ZJADc69">1914.54 (2356.85)</s><s xml:id="_7fWsrbv">2032.66 (2347.65)</s><s xml:id="_wVUUsE9">0.55 # Sedentary lifestyle Daily hours a day watching television, mean (SD) 3.52 (1.78) 3.64 (1.79) 3.48 (1.96) 3.44 (1.62) 0.56 # Daily hours a day sitting in front of computer/ mobile/tablet screen, mean (SD) 0.98 (1.55) 1.18 (1.80) 0.92 (1.42) 0.85 (1.39) 0.37 # Daily hours a day sitting in any means of transportation, mean (SD) 0.33 (0.67) 0.27 (0.36) 0.29 (0.65) 0.41 (0.85) 0.46 # Daily hours a day sitting, mean (SD) 4.57 (1.83) 4.84 (1.82) 4.45 (2.09) 4.42 (1.61) 0.10 # Smoking habit Past or never smoker, n (%) 293 (80.3) 95 (79.8) 93 (87.7) 105 (75) 0.04* Current smoker, n (%) 72 (</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_A6TT8FK">Alcohol use</head><p xml:id="_3ttvNYs"><s xml:id="_PWnG5K8">Alcohol units/week, mean (SD)</s></p><p xml:id="_VpEuG7E"><s xml:id="_T9Qq8jN">.073) 2.600 (7.044) 0.03 # Low-risk consumption, n (%) 346 (95.1%) 112 (94.1%) 100 (95.2%) 134 (95.7%) 0.83* Hazardous or risky consumption, n (%) 9 (2.5%) 7 (5.9%) 5 (4.8%) 6 (4.3%)</s><s xml:id="_Py2aBqp">Data are expressed as mean (SD) or N (%).</s><s xml:id="_DtAh4hf">BMI, Body Mass Index; WC, Waist Circumference; HC, Hip Circumference; WHR, Waist to Hip Ratio; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; TG, Triglyceride; Chol, Cholesterol; LDL, Low-Density Lipoprotein; HDL, High-Density Lipoprotein; HbA1c, Glycated hemoglobin; HOMA, homeostasis model assessment.</s><s xml:id="_npgPFGQ">$ One way ANOVA.</s><s xml:id="_BjrkWMe">*Chi Square.</s><s xml:id="_VfuBjDA"># Kruskal-Wallis Test.</s><s xml:id="_N7WFHUn">a,b Post Hoc test.</s></p><p xml:id="_qjFZHFa"><s xml:id="_4zs3ZE2">patients with prediabetes reported a recruitment rate of 10.4% <ref type="bibr" target="#b30">(31)</ref>.</s></p><p xml:id="_Nj8EBsU"><s xml:id="_SYr2UUj">Conversely, in a study targeting a multiethnic Asian population with prediabetes and using smartphone app-based lifestyle interventions, the recruitment rate for patients was notably higher at 52% <ref type="bibr" target="#b31">(32)</ref>.</s><s xml:id="_YqMxFSK">The higher recruitment rate observed in our study can be attributed to several factors.</s><s xml:id="_qb27BKn">First, we actively involved healthcare professionals and patients in the design and development of our recruitment strategies.</s><s xml:id="_5FcDa2m">As observed in a recent systematic review, actively engaging patients can successfully improve trials recruitment and retention rates <ref type="bibr" target="#b32">(33)</ref>.</s><s xml:id="_gKQ9MGX">Engaging patients in the design of the intervention through our qualitative interviews, as well as in the development of the recruitment materials (most notably in videos with patients and healthcare professionals explaining the trial and encouraging enrolment) could have been key driver of our success.</s></p><p xml:id="_ZvkmeQN"><s xml:id="_uERhRPC">Second, we provided comprehensive information to all team members involved in supporting the recruitment process.</s><s xml:id="_jPbYxY4">Additionally, our study implemented proactive measures, such as nurses visiting health centers for patient recruitment, and making multiple attempts to each potential participant before considering them for rejection.</s></p><p xml:id="_pPQsuBX"><s xml:id="_QcpdbXt">A recent systematic review comparing study samples recruited with virtual versus traditional recruitment methods observed that, although virtual recruitment samples are recruited faster, they are slightly younger, have more women participants, and are split on enrolment of racial minorities as compared to comparator studies <ref type="bibr" target="#b33">(34)</ref>.</s><s xml:id="_CX8yHFn">In our study our recruited sample was very similar to the overall population of people with diabetes in terms of gender, age, blood glucose and lipid profile.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9H5bwmp">Characteristics of the enrolled participants</head><p xml:id="_pwcq3sF"><s xml:id="_FhMNNfy">The study population had a mean age of 60 years, and 54% of them were women.</s><s xml:id="_RJrcZAU">This gender distribution closely aligns with the overall proportion of women in Spain's total population, which stands at 51% (35).</s><s xml:id="_Gq3RRCz">Regarding BMI of the study participants, 88.5% of them had a BMI of 25 or higher.</s><s xml:id="_eytMJbE">The prevalence of overweight or obesity in the study of Mexican-Americans patients with prediabetes by Vatcheva et al. was 86.9% which is very similar to our finding <ref type="bibr" target="#b34">(36)</ref>.</s><s xml:id="_83FXdfu">In our study, hypercholesterolemia was observed in approximately 49% of women and 38% of men.</s><s xml:id="_wH94ptJ">In contrast, a 2012 study in Spain among individuals with prediabetes reported a lower prevalence of 16% for women and 11% for men <ref type="bibr" target="#b35">(37)</ref>.</s><s xml:id="_F5JvR9k">Both studies highlighted lower levels of cholesterol in men compared to their female counterparts.</s><s xml:id="_5YvH4pM">Additionally, hypertension was found in 36.6% of women and 37% of men participants, which is lower than the percentages reported in similar studies involving participants with prediabetes in Spain, where the prevalence was 61.6% and 72.3%, respectively <ref type="bibr" target="#b35">(37,</ref><ref type="bibr" target="#b36">38)</ref>.</s></p><p xml:id="_JyyBUcY"><s xml:id="_39MCEbF">Evaluation of lifestyle characteristics of the patients showed that low adherence to the Mediterranean diet in our study participants was 67.4%.</s><s xml:id="_rTzqUKQ">Similar to our finding in a cohort study among individuals with prediabetes, low adherence to the Mediterranean diet was reported in 73% of participants <ref type="bibr" target="#b37">(39)</ref>.</s><s xml:id="_43ufcgb">Additionally, about 52.3% of our study participants were categorized as not very physically active.</s><s xml:id="_4n77p87">Although the method of assessing physical activity in a similar study in patients with prediabetes was different from our study, 50.6% of the participants did not have weekly physical activity <ref type="bibr" target="#b38">(40)</ref>.</s><s xml:id="_yKardQa">In another study in Spain, 55% of patients with prediabetes were physically inactive <ref type="bibr" target="#b37">(39)</ref>.</s><s xml:id="_t3SWqHj">Regarding alcohol drinking habits, 4.9% of our study participants exhibited hazardous or risky alcohol consumption.</s><s xml:id="_K5nr7PS">In contrast, a study in Spain reported a prevalence of alcohol consumption of 12.7% for women and 34.1% for men with prediabetes <ref type="bibr" target="#b35">(37)</ref>.</s><s xml:id="_TRKS2NW">The differences in the prevalence of alcohol consumption may be attributed to the use of different classification criteria.</s></p><p xml:id="_tkQTwRX"><s xml:id="_fEDJjNy">The variations in baseline variables among our study participants and similar studies in prediabetes patients may be attributed to differences in criteria for defining prediabetes.</s><s xml:id="_GH3Xc84">For instance, in the study by Diaz-Redondo et al. in Spain, prediabetes was defined as having FPG levels between 100 and 125 mg/dl, and/ or an HbA1c range from 5.7% (39 mmol/mol) to 6.4% (46 mmol/ mol) in the preceding 6 months <ref type="bibr" target="#b35">(37)</ref>.</s><s xml:id="_y3vSThD">Nevertheless, despite some differences, the overall similarity of most variables to other prediabetes studies enhances the generalizability of the findings of this clinical trial to a wide range of patients with prediabetes across different populations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ed6vmJk">Strength and limitations</head><p xml:id="_3RgVXEN"><s xml:id="_hFJJHSc">Our study has a number of strengths.</s><s xml:id="_ZwHAjuM">First, we developed an intervention following best-in-class recommendations for the development of complex interventions <ref type="bibr" target="#b28">(29)</ref>.</s><s xml:id="_aygwX3m">By conducting formative qualitative research with end users (healthcare professionals and patients), we were able to identify the main barriers and challenges that a digital intervention should take into consideration to successfully promote lifestyle change behavior among people at risk of diabetes type 2. Second, an important strength of PREDIABETEXT is its scalability at a low cost, thus representing a sustainable strategy for healthcare systems.</s><s xml:id="_V92XGFB">We opted for a low-intensity intervention in an effort to improve the very low participation and retention rates typically observed in higher intensity, face-to-face programs, such as the DPP.</s><s xml:id="_tu6h5AE">Third, the fact that the PREDIABETEXT intervention is delivered under real world conditions, using resources from the Balearic Islands health services (secure access to electronic health records, SMS platform, moodle platform for online training) has two important advantages: better estimation of the impact of the intervention in routine clinical practice, and that the intervention can be instantly transferred to the health service if deemed appropriate.</s><s xml:id="_WGKDmXN">Additional strengths of our study are the use of validated questionnaires and blinded outcome assessors (which supports the internal validity of our results), and the fact that the enrolled patients are representative of the overall population of people with prediabetes in the Balearic Islands (which supports the external validity).</s></p><p xml:id="_XXsMncg"><s xml:id="_MbRyzCt">Our study has also some limitations.</s><s xml:id="_eqMpKud">First, the use of selfreported measures for physical activity and dietary habits could introduce information and recall bias.</s><s xml:id="_44XxjEW">The use of objective measures, such as pedometers, could have contributed to overcome these limitations.</s><s xml:id="_6JzmD9t">Second, the exclusion of non-Spanish speaking individuals from minority groups may limit its generalizability.</s><s xml:id="_eS5334E">A potential limitation of our study is that we did not fully achieve the sample size initially calculated for the trial.</s><s xml:id="_UKcvFkH">While we successfully recruited a representative sample of patients and healthcare professionals, the slightly lower participant numbers may have reduced the statistical power to detect smaller effect sizes.</s><s xml:id="_mMdJn92">However, the achieved sample remains robust for examining the primary outcomes and provides valuable insights into the feasibility and impact of the intervention under real-world conditions.</s><s xml:id="_cNWXx9S">Our study may have failed to enroll hard-to-reach groups, as a key entry criterion implied having a recently recorded test result.</s><s xml:id="_CnXY8jC">Socially vulnerable groups are at higher risk of developing type 2 diabetes, but at the same time are less likely to visit their primary care center.</s><s xml:id="_NXp2Gud">Future trials on this area should design and implement recruitment strategies more suitable to better engage harder to reach groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7KKkv2n">Conclusions</head><p xml:id="_cvcF6fP"><s xml:id="_w6EBMx6">Prediabetic adults with a variety of demographic and lifestyle characteristics have been successfully enrolled in the PREDIABETEX trial.</s><s xml:id="_APBNMFb">These participants exhibit a range of metabolic conditions such as obesity, hyperglycemia, hyperinsulinemia, and dyslipidemia, all of which are associated with an elevated risk of developing diabetes and CVD.</s><s xml:id="_WHMVyz2">It is noteworthy that this study differs from most health interventions, as it focuses on implementing preventive interventions in individuals with prediabetes, a high-risk population for diabetes and its associated complications.</s><s xml:id="_6emXCNW">The findings of this trial might have significant implications for primary care physicians, healthcare professionals, and other stakeholders in T2DM prevention and management.</s><s xml:id="_nnUFKyp">Further research is needed to assess the intervention's long-term sustainability, scalability, and potential cost-effectiveness.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 Participant</head><label>1</label><figDesc><div><p xml:id="_aDAwEBe"><s xml:id="_nfsfXjE">FIGURE 1Participant flow diagram from enrolment to randomization.</s></p></div></figDesc><graphic coords="5,111.40,474.80,372.70,250.75" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1</head><label>1</label><figDesc><div><p xml:id="_h8NPp4P"><s xml:id="_m4GAW6Y">Baseline characteristics of the healthcare professionals by intervention group.</s></p></div></figDesc><table><row><cell>PROFESSIONALS</cell><cell>Total (n=58)</cell><cell>Control (n=20)</cell><cell>Intervention A (SMS) (n=18)</cell><cell>Intervention B (n=20) (SMS + training*)</cell><cell>P value</cell></row><row><cell>Demographic characteristics</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Women, n (%)</cell><cell>48 (82.8%)</cell><cell>15 (75.0%)</cell><cell>17 (94.4%)</cell><cell>16 (80.0%)</cell><cell>0.26</cell></row><row><cell>Age (years), mean (SD)</cell><cell>49.69 (10.15)</cell><cell>48.35 (11.51)</cell><cell>51.78 (9.28)</cell><cell>49.15 (9.66)</cell><cell>0.56</cell></row><row><cell>Nurses, n (%)</cell><cell>28 (48.3%)</cell><cell>10 (50.0%)</cell><cell>9 (50.0%)</cell><cell>9 (45.0%)</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.93</cell></row><row><cell>Medical doctors, n (%)</cell><cell>30 (51.7%)</cell><cell>10 (50.0%)</cell><cell>9 (50.0%)</cell><cell>11 (55.0%)</cell><cell></cell></row><row><cell>Years of working, mean (SD)</cell><cell>23.59 (9.22)</cell><cell>22.75 (10.02)</cell><cell>23.17 (8.56)</cell><cell>24.80 (9.29)</cell><cell>0.76</cell></row><row><cell>Professional works in a teaching center, n (%)</cell><cell>16 (28.1%)</cell><cell>8 (40.0%)</cell><cell>3 (17.6%)</cell><cell>5 (25.0%)</cell><cell>0.29</cell></row><row><cell>Mean (SD) number of patients assigned per healthcare professional</cell><cell>1924.12 (387.31)</cell><cell>1846.10 (342.95)</cell><cell>1996.50 (437.35)</cell><cell>1937.00 (386.94)</cell><cell>0.48</cell></row><row><cell>Mean (SD) number of patients recruited linked to healthcare professional</cell><cell>6.29 (3.60)</cell><cell>5.95 (3.72)</cell><cell>5.83 (3.47)</cell><cell>7.05 (3.66)</cell><cell>0.51</cell></row></table><note xml:id="_57D5Rjy"><p><s xml:id="_RAQb9nm">SMS, Short Message Service; SD, Standard Deviation.</s><s xml:id="_jPBf9FR">*Health care professional training.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE 2</head><label>2</label><figDesc><div><p xml:id="_fBYYX9T"><s xml:id="_FGJuPsJ">Baseline demographic, clinical, and lifestyle variables of the patients according to the three trial arms.</s></p></div></figDesc><table><row><cell>Mira-Martı ´nez et al.</cell><cell></cell><cell></cell><cell></cell><cell cols="2">10.3389/fendo.2025.1524336</cell></row><row><cell></cell><cell>total (n=365)</cell><cell>Control (n=119)</cell><cell>Intervention A (SMS) (n=106)</cell><cell>Intervention B (SMS + training) (n=140)</cell><cell>P value $</cell></row><row><cell>Demographic characteristics</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Women, n (%)</cell><cell>199 (54.5%)</cell><cell>69 (58%)</cell><cell>54 (50.9%)</cell><cell>76 (54.3%)</cell><cell>0.57</cell></row><row><cell>Age (years), mean (SD)</cell><cell>59.79 (9.75)</cell><cell>60.75</cell><cell>58.66 (9.60)</cell><cell>59.84 (9.83)</cell><cell>0.27</cell></row><row><cell></cell><cell></cell><cell>(9.77)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Clinical characteristics, mean (SD)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Height (cm), mean (SD)</cell><cell>162.82</cell><cell>162.29</cell><cell>163.28 (9.49)</cell><cell>162.93 (9.24)</cell><cell>0.72</cell></row><row><cell></cell><cell>(9.45)</cell><cell>(9.70)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Weight (kg)</cell><cell>84.38</cell><cell>84.71</cell><cell>84.57 (16.63)</cell><cell>83.96 (17.22)</cell><cell>0.94</cell></row><row><cell></cell><cell>(18.61)</cell><cell>(21.73)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>BMI (kg/m2), mean (SD)</cell><cell>31.72 (5.97)</cell><cell>31.98</cell><cell>31.67 (5.56)</cell><cell>31.54 (5.47)</cell><cell>0.12</cell></row><row><cell></cell><cell></cell><cell>(6.78)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>WC (cm), mean (SD)</cell><cell>103.77</cell><cell>103.49</cell><cell>103.92(11.48)</cell><cell>103.89 (11.49)</cell><cell>0.82 #</cell></row><row><cell></cell><cell>(13.10)</cell><cell>(15.77)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>HC (cm), mean (SD)</cell><cell>110.06</cell><cell>110.93</cell><cell>109.35 (10.64)</cell><cell>109.87 (10.66)</cell><cell>0.65 #</cell></row><row><cell></cell><cell>(11.74)</cell><cell>(13.76)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>WHR</cell><cell>0.94 (0.08)</cell><cell>0.93 (0.09)</cell><cell>0.95 (0.07)</cell><cell>0.94 (0.07)</cell><cell>0.20 #</cell></row><row><cell>SBP (mmHg), mean (SD)</cell><cell>133.35</cell><cell>130.78</cell><cell>135.22 (16.42)</cell><cell>134.10 (14.63)</cell><cell>0.07</cell></row><row><cell></cell><cell>(15.50)</cell><cell>(15.45)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>DBP (mmHg), mean (SD)</cell><cell>76.34</cell><cell>74.60</cell><cell>78.75 (11.04) a,b</cell><cell>75.97 (9.97) b</cell><cell>0.01</cell></row><row><cell></cell><cell>(10.80)</cell><cell>(11.19) a</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Glucose (mg/dl), mean (SD)</cell><cell>104.28</cell><cell>102.90</cell><cell>105.18 (13.03)</cell><cell>104.78 (14.16)</cell><cell>0.37</cell></row><row><cell></cell><cell>(13.22)</cell><cell>(12.20)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>TG (mg/dl), mean (SD)</cell><cell>141.09</cell><cell>123.48</cell><cell>156.85 (118.26)</cell><cell>144.22 (99.79)</cell><cell>0.18 #</cell></row><row><cell></cell><cell>(94.63)</cell><cell>(54.17)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Chol (mg/dl), mean (SD)</cell><cell>194.72</cell><cell>195.98</cell><cell>195.33 (34.78)</cell><cell>193.14 (39.83)</cell><cell>0.826</cell></row><row><cell></cell><cell>(38.53)</cell><cell>(40.39)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>LDL (mg/dl), mean (SD)</cell><cell>117.68</cell><cell>121.62</cell><cell>116.88 (28.15)</cell><cell>114.83 (35.41)</cell><cell>0.09 #</cell></row><row><cell></cell><cell>(33.61)</cell><cell>(35.62)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>HDL (mg/dl), mean (SD)</cell><cell>49.70</cell><cell>50.22</cell><cell>48.63 (11.27)</cell><cell>50.07 (11.69)</cell><cell>0.532</cell></row><row><cell></cell><cell>(11.60)</cell><cell>(11.82)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>TG/HDL</cell><cell>3.17 (3.58)</cell><cell>2.65 (1.61)</cell><cell>3.66 (3.67)</cell><cell>3.25 (4.57)</cell><cell>0.22 #</cell></row><row><cell>Chol/HDL</cell><cell>3.97 (1.22)</cell><cell>3.98 (1.03)</cell><cell>4.16 (1.26)</cell><cell>3.82 (1.31)</cell><cell>0.17 #</cell></row><row><cell>HbA1c (%), mean (SD)</cell><cell>6.13 (0.16)</cell><cell>6.13 (0.15)</cell><cell>6.13 (0.15)</cell><cell>6.15 (0.18) $</cell><cell>0.32 #</cell></row><row><cell>Insulin level (U/ml), mean (SD)</cell><cell>17.77(15.55)</cell><cell>15.42(7.88)</cell><cell>18.80 (13.7)</cell><cell>18.76(20.87)</cell><cell>0.67 #</cell></row><row><cell>HOMA, mean (SD)</cell><cell>4.86 (5.45)</cell><cell>3.89 (2.26)</cell><cell>4.87 (3.70)</cell><cell>5.58 (7.76)</cell><cell>0.74 #</cell></row><row><cell>REGICOR, mean (SD)</cell><cell>4.04 (2.65)</cell><cell>5.11 (4.30)</cell><cell>3.98 (2.25)</cell><cell>4.26 (2.95)</cell><cell>0.58 #</cell></row><row><cell>Categories of Framingham-REGICOR</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Low risk, n (%)</cell><cell>257 (72.4)</cell><cell>85 (73.3)</cell><cell>74 (70.5)</cell><cell>98 (73.1)</cell><cell>0.87</cell></row><row><cell>Moderate or high risk, n (%)</cell><cell>98 (27.6)</cell><cell>31 (26.7)</cell><cell>31 (29.5)</cell><cell>36 (26.9)</cell><cell></cell></row><row><cell>Adherence to Mediterranean diet</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>MEDAS_score, mean (SD)</cell><cell>7.52 (2.04)</cell><cell>7.41 (2.08)</cell><cell>7.56 (2.35)</cell><cell>7.58 (1.74)</cell><cell>0.783 #</cell></row><row><cell>Low adherence, n (%)</cell><cell>246 (67.4%)</cell><cell>83 (69.7%)</cell><cell>65 (61.3%)</cell><cell>98 (70.0%)</cell><cell>0.285*</cell></row><row><cell>Good adherence, n (%)</cell><cell>119 (32.6%)</cell><cell>36 (30.3%)</cell><cell>41 (38.7%)</cell><cell>42 (30.0%)</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(Continued)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_JmadJfJ"><s xml:id="_QQDbTmZ">Mira-Martı ´nez et al. 10.3389/fendo.2025.1524336</s><s xml:id="_Y4DvY4g">Frontiers in Endocrinology frontiersin.org</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_TRkvavx"><s xml:id="_jz3Jbjx">Frontiers in Endocrinology frontiersin.org</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_rcpm5UH">Acknowledgments</head><p xml:id="_NbunMpu"><s xml:id="_kcqrEdB">We are thankful to all the patients and healthcare professionals that took part in this study.</s><s xml:id="_e7bSgzq">We thank the PRISIB platform from the <rs type="institution">Balearic Islands Research Institute</rs>, for facilitating the lists of potentially eligible patients and healthcare professionals.</s><s xml:id="_zxhpDyv">The authors would like to thank reviewers and editors for their suggestions and comments.</s></p></div>
			</div>
			<div type="funding">
<div><head xml:id="_NdsRfqd">Funding</head><p xml:id="_WeM6K6A"><s xml:id="_rTBAhjD">The author(s) declare that financial support was received for the research, authorship, and/or publication of this article.</s><s xml:id="_UyxkuBp">This study was funded by the <rs type="funder">Health Research Institute of the Balearic Islands (IdISBa)</rs> through the intramural project "<rs type="grantNumber">SYN20/04</rs>" It was also supported by <rs type="funder">Instituto de Salud Carlos III (ISCIII)</rs> through the project <rs type="grantNumber">RD21/0016/0009</rs>, co-financed with funds from <rs type="funder">Unio ́n Europea -NextGenerationEU</rs>, which funds the actions of the <rs type="projectName">Recovery and Resilience Facility</rs>.</s><s xml:id="_grAxynD"><rs type="projectName">MAF-dR</rs> was funded by the <rs type="funder">Health Research Institute of the Balearic Islands</rs> (grant number <rs type="grantNumber">FOLIUM19/05</rs>; funded by <rs type="grantNumber">ITS-2019-003</rs>).</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_JFvpQqm">
					<idno type="grant-number">SYN20/04</idno>
				</org>
				<org type="funding" xml:id="_7DKGzhZ">
					<idno type="grant-number">RD21/0016/0009</idno>
				</org>
				<org type="funded-project" xml:id="_fy8Vbw2">
					<orgName type="project" subtype="full">Recovery and Resilience Facility</orgName>
				</org>
				<org type="funded-project" xml:id="_vEE7jZe">
					<idno type="grant-number">FOLIUM19/05</idno>
					<orgName type="project" subtype="full">MAF-dR</orgName>
				</org>
				<org type="funding" xml:id="_bRcf7fu">
					<idno type="grant-number">ITS-2019-003</idno>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_zQK6cGU">Data availability statement</head><p xml:id="_Vaqyx2w"><s xml:id="_9kqYVGr">The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2m3GgGp">Ethics statement</head><p xml:id="_EbcqxFG"><s xml:id="_yuU3tM5">The study complies with the ethical standards of the Declaration of Helsinki and all procedures were approved in June 2021 by the Institutional Research Ethics Review Board of the Balearic Islands Health Service (CEI-IB Ref No: IB4495/21PI).</s><s xml:id="_eVRdzXV">Participants' consent was obtained, and all data collected was kept confidential and anonymous.</s><s xml:id="_XxScMjg">The studies were conducted in accordance with the local legislation and institutional requirements.</s><s xml:id="_ajaC6yJ">The participants provided their written informed consent to participate in this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ekGTp6X">Conflict of interest</head><p xml:id="_Jwb9kYP"><s xml:id="_KPwh59M">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mfnqAQ2">Generative AI statement</head><p xml:id="_JPgeCYf"><s xml:id="_3gZhsvJ">The author(s) declare that no Generative AI was used in the creation of this manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VzW6tnm">Publisher's note</head><p xml:id="_GnVs9tw"><s xml:id="_ZpwwKqz">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.</s><s xml:id="_Kt7Drey">Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_cEPwXgv">Supplementary material</head><p xml:id="_vJNEGVS"><s xml:id="_FTpbyK5">The Supplementary Material for this article can be found online at: <ref type="url" target="https://www.frontiersin.org/articles/10.3389/fendo.2025.1524336/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2025.  1524336/full#supplementary-material</ref></s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_MtgYgFy">report of a WHO/IDF consultation</title>
		<idno type="DOI">10.1002/(sici)1096-9136(199807)15:7&lt;539::aid-dia668&gt;3.0.co;2-s</idno>
	</analytic>
	<monogr>
		<title level="m" xml:id="_Tw9vVD8">Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia</title>
		<imprint>
			<publisher>World Health Organization, International Diabetes Federation</publisher>
			<date type="published" when="2005">2005</date>
			<biblScope unit="page">46</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. (2005). 46 p.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_3DrSXFq">Global prevalence of prediabetes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Rooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ogurtsova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ozkan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Echouffo-Tcheugui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Boyko</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc22-2376</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_33F5BPZ">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1388" to="1394" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rooney MR, Fang M, Ogurtsova K, Ozkan B, Echouffo-Tcheugui JB, Boyko EJ, et al. Global prevalence of prediabetes. Diabetes Care. (2023) 46:1388-94. doi: 10.2337/ dc22-2376</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_quMmXTG">Prediabetes: diagnosis, evaluation of chronic complications, and treatment</title>
		<author>
			<persName><forename type="first">Furtado</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Gerchman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leitão</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename></persName>
		</author>
		<idno type="DOI">10.1590/s0004-27302012000500001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mpJAZUv">Arq Bras Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="275" to="284" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Furtado De Souza C, Gross JL, Gerchman F, Leitão CB. Prediabetes: diagnosis, evaluation of chronic complications, and treatment. Arq Bras Endocrinol Metab. (2012) 56(5):275-84. Portuguese. doi: 10.1590/s0004-27302012000500001</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_cJ7xKVR">Impaired fasting glucose and impaired glucose tolerance: Implications for care</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Defronzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Heine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pratley</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc07-9920</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aasZ2vx">Diabetes Care</title>
		<imprint>
			<biblScope unit="page" from="753" to="759" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care. In: Diabetes Care. (2007) p:753-9. doi: 10.2337/dc07-9920</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_9PvcmpQ">Global epidemiology of prediabetes -present and future perspectives</title>
		<author>
			<persName><forename type="first">U</forename><surname>Hostalek</surname></persName>
		</author>
		<idno type="DOI">10.1186/s40842-019-0080-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_p8zzgJP">Clin Diabetes Endocrinol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">5</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hostalek U. Global epidemiology of prediabetes -present and future perspectives. Clin Diabetes Endocrinol. (2019) 5:5. doi: 10.1186/s40842-019-0080-0</note>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<idno type="DOI">10.2174/1573399819666230413094200</idno>
		<ptr target="www.diabetesatlas.org" />
		<title level="m" xml:id="_3VN9SqG">IDF Diabetes Atlas</title>
		<imprint>
			<date type="published" when="2021-11-22">2021. November 22, 2022</date>
		</imprint>
	</monogr>
	<note>10th edition</note>
	<note type="raw_reference">IDF Diabetes Atlas 10th edition. (2021). Available online at: www.diabetesatlas. org (Accessed November 22, 2022).</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_rmeypHx">Effects of lifestyle changes on adults with prediabetes: A systematic review and metaanalysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Glechner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Keuchel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Affengruber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Titscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Sommer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Matyas</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pcd.2018.07.003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pUTt7sU">Primary Care Diabetes</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="393" to="408" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Glechner A, Keuchel L, Affengruber L, Titscher V, Sommer I, Matyas N, et al. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta- analysis. Primary Care Diabetes. (2018) 12:393-408. doi: 10.1016/j.pcd.2018.07.003</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_JE2pRVu">Prediabetes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Khetan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rajagopalan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cjca.2017.12.030</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_R2b2tYk">Can J Cardiol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="615" to="623" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Khetan AK, Rajagopalan S. Prediabetes. Can J Cardiol. (2018) 34:615-23. doi: 10.1016/j.cjca.2017.12.030</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_FACgmuZ">Lifestyle and progression to type 2 diabetes in a cohort of workers with prediabetes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bennasar-Veny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fresneda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Loṕez-Gonzaĺez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Busquets-Corteś</surname></persName>
		</author>
		<author>
			<persName><surname>Aguilóa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Yañez</surname></persName>
		</author>
		<idno type="DOI">10.3390/nu12051538</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DVVtnCM">Nutrients</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">1538</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bennasar-Veny M, Fresneda S, Loṕez-Gonzaĺez A, Busquets-Corteś C, AguilóA, Yañez AM. Lifestyle and progression to type 2 diabetes in a cohort of workers with prediabetes. Nutrients. (2020) 12(5):1538. doi: 10.3390/nu12051538</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_KKfRdmV">Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Knowler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Barrett-Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Fowler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Hamman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lachin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Walker</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa012512</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_syA88JU">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="page" from="393" to="403" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. (2002) 346:393-403. doi: 10.1056/ NEJMoa012512</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_9Wjjz76">Prevalence and correlates of diabetes prevention program referral and participation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Venkataramani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Pollack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Maruthur</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2018.10.005</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6CkktPr">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="452" to="457" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Venkataramani M, Pollack CE, Yeh HC, Maruthur NM. Prevalence and correlates of diabetes prevention program referral and participation. Am J Prev Med. (2019) 56:452-7. doi: 10.1016/j.amepre.2018.10.005</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_NeTfYFZ">Retention among participants in the national diabetes prevention program lifestyle change program, 2012-2017</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Cannon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Masalovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Soler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jabrah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Ely</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc19-2366</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_najkpxz">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="2042" to="2049" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cannon MJ, Masalovich S, Ng BP, Soler RE, Jabrah R, Ely EK, et al. Retention among participants in the national diabetes prevention program lifestyle change program, 2012-2017. Diabetes Care. (2020) 43:2042-9. doi: 10.2337/dc19-2366</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_N4gN27D">Mobile health technology in the primary prevention of type 2 diabetes: a systematic review</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Barengo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Diaz</forename><surname>Valencia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Apolina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Estrada</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Fernańdez</forename><surname>Garate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Correa</forename><surname>Gonzaĺez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="DOI">10.1007/s11892-021-01445-w</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rgFrHvf">Curr Diabetes Rep</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Barengo NC, Diaz Valencia PA, Apolina LM, Estrada Cruz NA, Fernańdez Garate JE, Correa Gonzaĺez RA, et al. Mobile health technology in the primary prevention of type 2 diabetes: a systematic review. Curr Diabetes Rep. (2022) 22:1- 10. doi: 10.1007/s11892-021-01445-w</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_39x6av5">The use of mobile health interventions for outcomes among middle-aged and elderly patients with prediabetes: A systematic review</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Jeem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Andriani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nabila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Emelia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lazuardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Koesnanto</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijerph192013638</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Hpdn9VB">Int J Environ Res Public Health</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page">13638</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jeem YA, Andriani RN, Nabila R, Emelia DD, Lazuardi L, Koesnanto H. The use of mobile health interventions for outcomes among middle-aged and elderly patients with prediabetes: A systematic review. Int J Environ Res Public Health. (2022) 19 (20):13638. doi: 10.3390/ijerph192013638</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_ucd54bF">Lower-intensity interventions for prediabetes: A systematic review</title>
		<author>
			<persName><forename type="first">E</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Meza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Maruthur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2023.05.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_w3ZqRpv">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="906" to="915" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tseng E, Lam KY, Meza KA, O&apos;Brien MJ, Maruthur NM. Lower-intensity interventions for prediabetes: A systematic review. Am J Prev Med. (2023) 65:906- 15. doi: 10.1016/j.amepre.2023.05.012</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_mTsWZn6">Development and evaluation of a digital health intervention to prevent type 2 diabetes in primary care: the PREDIABETEXT study protocol for a randomised clinical trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Galmes-Panades</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Angullo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mira</forename><surname>Martıńez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bennasar-Veny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zamanillo-Campos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Goḿez-Juanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="DOI">10.3390/ijerph192214706</idno>
		<ptr target="https://www.mdpi.com/1660-4601/19/22/14706" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ScHQcwp">Int J Environ Res Public Health</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page">14706</biblScope>
			<date type="published" when="2022-11-22">2022. November 22, 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Galmes-Panades AM, Angullo E, Mira Martıńez S, Bennasar-Veny M, Zamanillo-Campos R, Goḿez-Juanes R, et al. Development and evaluation of a digital health intervention to prevent type 2 diabetes in primary care: the PREDIABETEXT study protocol for a randomised clinical trial. Int J Environ Res Public Health. (2022) 19(22):14706. https://www.mdpi.com/1660-4601/19/22/14706 (Accessed November 22, 2022).</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_8uCF5f5">Engaging Primary Care Professionals and People at Risk of Type 2 Diabetes in the Design of PREDIABETEXT, a Multifaceted Digital Intervention Aimed at Preventing Type 2 Diabetes: A Qualitative Study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Serrano-Ripoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zamanillo-Campos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mira</forename><surname>Martıńez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Fiol-Deroque</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Malih</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Angullo-Martıńez</surname></persName>
		</author>
		<idno type="DOI">10.3390/diabetology6010001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_23GtUmA">Diabetology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Serrano-Ripoll MJ, Zamanillo-Campos R, Mira Martıńez S, Fiol-deRoque MA, Malih N, Angullo-Martıńez E, et al. Engaging Primary Care Professionals and People at Risk of Type 2 Diabetes in the Design of PREDIABETEXT, a Multifaceted Digital Intervention Aimed at Preventing Type 2 Diabetes: A Qualitative Study. Diabetology. (2025) 6:1. doi: 10.3390/diabetology6010001</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_WrR8MnW">A Short screener is valid for assessing mediterranean diet adherence among older spanish men and women</title>
		<author>
			<persName><forename type="first">H</forename><surname>Schröder</surname></persName>
		</author>
		<author>
			<persName><surname>Fitóm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Estruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Martıńez-Gonzaĺez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Corella</forename><forename type="middle">D</forename><surname>Salas-Salvadój</surname></persName>
		</author>
		<idno type="DOI">10.3945/jn.110.135566</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2PX3Bg7">J Nutr</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="1140" to="1145" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schröder H, FitóM, Estruch R, Martıńez-Gonzaĺez MA, Corella D, Salas-SalvadóJ, et al. A Short screener is valid for assessing mediterranean diet adherence among older spanish men and women. J Nutr. (2011) 141:1140-5. doi: 10.3945/jn.110.135566</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_9jJZQxJ">Validation of the regicor short physical activity questionnaire for the adult population</title>
		<author>
			<persName><forename type="first">L</forename><surname>Molina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sarmiento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peñafiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Donaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Garcia-Aymerich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gomez</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0168148</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YdDAc3w">PloS One</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">168148</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Molina L, Sarmiento M, Peñafiel J, Donaire D, Garcia-Aymerich J, Gomez M, et al. Validation of the regicor short physical activity questionnaire for the adult population. PloS One. (2017) 12:e0168148. doi: 10.1371/journal.pone.0168148</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_EgQwjrG">Validation of the Spanish version of the physical activity questionnaire used in the Nurses&apos; Health Study and the Health Professionals&apos; Follow-up Study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Martıńez-Gonzaĺez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>López-Fontana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Varo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sańchez-Villegas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Martinez</surname></persName>
		</author>
		<idno type="DOI">10.1079/phn2005745</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UWpSM9g">Public Health Nutr</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="920" to="927" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Martıńez-Gonzaĺez MA, López-Fontana C, Varo JJ, Sańchez-Villegas A, Martinez JA. Validation of the Spanish version of the physical activity questionnaire used in the Nurses&apos; Health Study and the Health Professionals&apos; Follow-up Study. Public Health Nutr. (2005) 8:920-7. doi: 10.1079/phn2005745</note>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<idno type="DOI">10.1136/tobaccocontrol-2012-050582</idno>
		<ptr target="https://cdn.who.int/media/docs/default-source/ncds/ncd-surveillance/gats/06_gats_corequestionnairewithoptionalquestions.pdf?sfvrsn=3b5ca226_15" />
		<title level="m" xml:id="_QAZJ7Nj">Global Adult Tobacco Survey (GATS): Core Questionnaire with Optional Questions</title>
		<meeting><address><addrLine>Atlanta, GA</addrLine></address></meeting>
		<imprint>
			<publisher>Centers for Disease Control and Prevention</publisher>
			<date type="published" when="2020-11-22">2020. November 22, 2022</date>
		</imprint>
		<respStmt>
			<orgName>Global Adult Tobacco Survey Collaborative Group</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Global Adult Tobacco Survey Collaborative Group. Global Adult Tobacco Survey (GATS): Core Questionnaire with Optional Questions. Atlanta, GA: Centers for Disease Control and Prevention (2020). Available online at: chrome-extension:// efaidnbmnnnibpcajpcglclefindmkaj/https://cdn.who.int/media/docs/default-source/ ncds/ncd-surveillance/gats/06_gats_corequestionnairewithoptionalquestions.pdf? sfvrsn=3b5ca226_15 (Accessed November 22, 2022).</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<idno type="DOI">10.21134/haaj.v23i1.741</idno>
		<ptr target="https://www" />
		<title level="m" xml:id="_tycsCay">Cuantificacioń del consumo de alcohol</title>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cuantificacioń del consumo de alcohol (2020). Available online at: https://www.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_NGvv7dw">ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)</title>
		<author>
			<persName><forename type="first">B</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mancia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Spiering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Agabiti</forename><surname>Rosei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Azizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Burnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1093/eurheartj/ehy339</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WbS5s5Y">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="3021" to="3104" />
			<date type="published" when="2018">2018. 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. (2018) 39:3021-104. doi: 10.1093/eurheartj/ehy339</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_ww6U7qV">Coronary risk estimation in Spain using a calibrated Framingham function</title>
		<author>
			<persName><forename type="first">J</forename><surname>Marrugat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Solanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D'</forename><surname>Agostino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ordovas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cordoń</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
		<idno type="DOI">10.1016/s0300-8932(03)76861-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FDacdff">Rev Esp Cardiol</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="253" to="261" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Marrugat J, Solanas P, D&apos;Agostino R, Sullivan L, Ordovas J, Cordoń F, et al. Coronary risk estimation in Spain using a calibrated Framingham function. Rev Esp Cardiol. (2003) 56:253-61. doi: 10.1016/S0300-8932(03)76861-4</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_PkrmSXr">Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Hosker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Rudenski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Naylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Treacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Turner</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf00280883</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6BsPE56">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="412" to="419" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. (1985) 28:412-9. doi: 10.1007/BF00280883</note>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main" xml:id="_HepSxpw">Waist circumference and waist-hip ratio: report of a WHO expert consultation</title>
		<imprint>
			<date type="published" when="2008-12-11">8-11 December 2008. 2011</date>
			<publisher>World Health Organization</publisher>
			<biblScope unit="page">39</biblScope>
			<pubPlace>Geneva; Geneva</pubPlace>
		</imprint>
		<respStmt>
			<orgName>World Health Organization</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008. Geneva: World Health Organization (2011). 39 p.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_hsg3BJf">The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Michie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Richardson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Francis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hardeman</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12160-013-9486-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rTa7ZNU">Ann Behav Med</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="81" to="95" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. (2013) 46:81-95. doi: 10.1007/s12160-013-9486-6</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_ADwT6KU">The behaviour change wheel: A new method for characterising and designing behaviour change interventions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Michie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Van Stralen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>West</surname></persName>
		</author>
		<idno type="DOI">10.1186/1748-5908-6-42</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RCK4kEm">Implementation Sci</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">42</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Michie S, van Stralen MM, West R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Sci. (2011) 6:42. doi: 10.1186/1748-5908-6-42</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_ezUSaMS">Patients recruitment forecast in clinical trials</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Pateria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Singh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_U5bEHJR">Cognizant</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Insights</note>
	<note type="raw_reference">Pateria DK, Singh RK. Patients recruitment forecast in clinical trials. Cognizant 20-20 Insights. (2015), 1-7.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_MjhQGES">A wearable technology delivering a web-based diabetes prevention program to people at high risk of type 2 diabetes: Randomized controlled trial</title>
		<author>
			<persName><forename type="first">E</forename><surname>Staite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bayley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Al-Ozairi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hopkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rundle</surname></persName>
		</author>
		<idno type="DOI">10.2196/15448</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_956Qahu">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">15448</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Staite E, Bayley A, Al-Ozairi E, Stewart K, Hopkins D, Rundle J, et al. A wearable technology delivering a web-based diabetes prevention program to people at high risk of type 2 diabetes: Randomized controlled trial. JMIR Mhealth Uhealth. (2020) 8(7): e15448. doi: 10.2196/15448</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_sZMqH2x">A pilot and feasibility study of a randomized clinical trial testing a self-compassion intervention aimed to increase physical activity behaviour among people with prediabetes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Signore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Semenchuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kullman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Tefft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Webber</surname></persName>
		</author>
		<idno type="DOI">10.1186/s40814-022-01072-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uvhkhyD">Pilot Feasibil Stud</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">111</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Signore AK, Jung ME, Semenchuk B, Kullman SM, Tefft O, Webber S, et al. A pilot and feasibility study of a randomized clinical trial testing a self-compassion intervention aimed to increase physical activity behaviour among people with prediabetes. Pilot Feasibil Stud. (2022) 8(1):111. doi: 10.1186/s40814-022-01072-6</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_cHhQzCZ">A smartphone appbased lifestyle change program for prediabetes (D&apos;LITE study) in a multiethnic asian population: A randomized controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Ong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Johal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">V</forename><surname>Yap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<idno type="DOI">10.3389/fnut.2021.780567</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kmfq8AS">Front Nutr</title>
		<imprint>
			<biblScope unit="page">8</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lim SL, Ong KW, Johal J, Han CY, Yap QV, Chan YH, et al. A smartphone app- based lifestyle change program for prediabetes (D&apos;LITE study) in a multiethnic asian population: A randomized controlled trial. Front Nutr. (2022) 8. doi: 10.3389/ fnut.2021.780567</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_JGQVzW7">Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Crocker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ricci-Cabello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Hirst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Petit-Zeman</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.k4738</idno>
		<ptr target="http://www.bmj.com/content/363/bmj.k4738.abstract" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_uUpcPpt">BMJ</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page">4738</biblScope>
			<date type="published" when="2018-11-22">2018. November 22, 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Crocker JC, Ricci-Cabello I, Parker A, Hirst JA, Chant A, Petit-Zeman S, et al. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. BMJ. (2018) 363:k4738. http://www.bmj.com/ content/363/bmj.k4738.abstract (Accessed November 22, 2022).</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_s2wDEvz">Comparison of study samples recruited with virtual versus traditional recruitment methods</title>
		<author>
			<persName><forename type="first">H</forename><surname>Moseson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Juusola</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.conctc.2020.100590</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZccYZKD">Contemp Clin Trials Commun</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">100590</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moseson H, Kumar S, Juusola JL. Comparison of study samples recruited with virtual versus traditional recruitment methods. Contemp Clin Trials Commun. (2020) :19:100590. doi: 10.1016/j.conctc.2020.100590</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_PSMze9u">Sex and age differences in prevalence and risk factors for prediabetes in Mexican-Americans</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Vatcheva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Fisher-Hoch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Reininger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Mccormick</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2019.107950</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pye8EPP">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page">107950</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vatcheva KP, Fisher-Hoch SP, Reininger BM, McCormick JB. Sex and age differences in prevalence and risk factors for prediabetes in Mexican-Americans. Diabetes Res Clin Pract. (2020) 159:107950. doi: 10.1016/j.diabres.2019.107950</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_MnzYNHw">Modifiable risk factors associated with prediabetes in men and women: A cross-sectional analysis of the cohort study in primary health care on the evolution of patients with prediabetes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dıáz-Redondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Giraĺdez-Garcıá</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Carrillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Serrano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Garcıá-Soidań</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Artola</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12875-014-0216-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3z4t775">BMC Fam Pract</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dıáz-Redondo A, Giraĺdez-Garcıá C, Carrillo L, Serrano R, Garcıá-Soidań FJ, Artola S, et al. Modifiable risk factors associated with prediabetes in men and women: A cross-sectional analysis of the cohort study in primary health care on the evolution of patients with prediabetes. BMC Fam Pract. (2015) 16:1-9. doi: 10.1186/s12875-014- 0216-3</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_5tXCpBV">Association of general and abdominal obesity with hypertension, dyslipidemia and prediabetes in the PREDAPS study</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Sangroś</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Torrecilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Giraĺdez-Garcıá</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Carrillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mancera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mur</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.rec.2017.04.035</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZPCnBuy">Rev Española Cardiologıá</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="170" to="177" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>English Edition</note>
	<note type="raw_reference">Sangroś FJ, Torrecilla J, Giraĺdez-Garcıá C, Carrillo L, Mancera J, Mur T, et al. Association of general and abdominal obesity with hypertension, dyslipidemia and prediabetes in the PREDAPS study. Rev Española Cardiologıá (English Edition). (2018) 71:170-7. doi: 10.1016/j.rec.2017.04.035</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_xfayNQb">Mediterranean diet and diabetes risk in a cohort study of individuals with prediabetes: propensity score analyses</title>
		<author>
			<persName><forename type="first">L</forename><surname>Cea-Soriano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pulido</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Franch-Nadal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mata-Cases</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dıéz-Espino</surname></persName>
		</author>
		<idno type="DOI">10.1111/dme.14768</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_V83Mg9x">Diabetic Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">14768</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cea-Soriano L, Pulido J, Franch-Nadal J, Santos JM, Mata-Cases M, Dıéz-Espino J, et al. Mediterranean diet and diabetes risk in a cohort study of individuals with prediabetes: propensity score analyses. Diabetic Med. (2022) 39(6):e14768. doi: 10.1111/dme.14768</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_ZGU9e9C">Associations of healthy dietary patterns with mortality among people with prediabetes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Geng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Qiu</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00394-022-03078-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jmcqqN8">Eur J Nutr</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1377" to="1387" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li L, Wan Z, Geng T, Lu Q, Zhu K, Qiu Z, et al. Associations of healthy dietary patterns with mortality among people with prediabetes. Eur J Nutr. (2022) 62(3):1377- 87. doi: 10.1007/s00394-022-03078-5</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
